Table 4.
Baseline Scores for the SF-36 and Sheehan Disability Scale From 4 Studies of Duloxetine for the Treatment of Fibromyalgia
| Duloxetine |
Placebo |
|||
| Measure (score range) | n | Mean (SD) | n | Mean (SD) |
| SF-36 score (0–100) | ||||
| Mental component summary | 717 | 44.5 (12.0) | 489 | 44.2 (11.3) |
| Physical component summary | 717 | 28.6 (7.9) | 489 | 28.4 (7.6) |
| Bodily pain | 723 | 30.2 (14.0) | 489 | 29.9 (14.1) |
| General health perception | 720 | 46.2 (21.2) | 489 | 44.3 (20.6) |
| Mental health | 723 | 63.6 (20.7) | 489 | 62.8 (19.2) |
| Physical functioning | 723 | 41.6 (22.1) | 489 | 42.4 (21.5) |
| Role limit, emotional | 720 | 53.1 (43.6) | 489 | 54.6 (42.7) |
| Role limit, physical | 721 | 16.3 (28.0) | 489 | 16.0 (26.4) |
| Social functioning | 722 | 56.0 (25.8) | 489 | 54.8 (24.4) |
| Vitality | 723 | 24.1 (19.2) | 489 | 22.8 (17.5) |
| Sheehan Disability Scale score | ||||
| Global impairment (0–30) | 718 | 16.5 (7.5) | 487 | 17.1 (7.0) |
| Work/school (0–10) | 628 | 5.6 (2.8) | 417 | 5.9 (2.5) |
| Family life (0–10) | 725 | 5.5 (2.7) | 489 | 5.7 (2.6) |
| Social life (0–10) | 724 | 5.4 (2.7) | 489 | 5.5 (2.6) |
Abbreviation: SF-36 = Medical Outcomes Study 36-Item Short-Form Health Survey.